共 50 条
- [21] Dimethyl 2,6-dimethyl-4-{3-[4-(methylsulfanyl)phenyl]-1H-pyrazol-4-yl}-1,4-dihydropyridine-3,5-dicarboxylate monohydrate ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2012, 68 : O3302 - +
- [22] Dimethyl 1,4-dihydro-4-(4-methoxyphenyl)-2,6-dimethylpyridine-3,5-dicarboxylate ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2010, 66 : O587 - U4776
- [24] Diethyl 2,6-dimethyl-4-[4-(3-phenylacryloyloxy) phenyl]-1,4-dihydropyridine-3,5-dicarboxylate hemihydrate ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2013, 69 : O389 - +
- [25] Dimethyl 2-[(E)-(hydroxyimino)methyl]-6-methyl-4-(2-thienyl)-1,4-dihydropyridine-3,5-dicarboxylate ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2007, 63 : O2240 - O2242
- [26] Diisopropyl 1-(4-methoxyphenyl)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2011, 67 : O2979 - U874
- [27] Nuclear magnetic resonance investigations of calcium-antagonist drugs .4. Conformational and dynamic features of nicardipine {methyl 2-[methyl(phenylmethyl)amino]ethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate} in deuterium oxide JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 2, 1997, (02): : 363 - 367
- [28] Diethyl 2,6-dimethyl-4-[5-(4-nitrophenyl)-2-furyl]-1,4-dihydropyridine-3,5-dicarboxylate ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2005, 61 : O3592 - O3594
- [29] 3-Methyl 5-[(S)-2-methylbutyl] 4-[2-(difluoromethoxy)phenyl]-2,6-dimethyl-1,4-dihydro- pyridine-3,5-dicarboxylate ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2002, 58 : o532 - o534
- [30] Dimethyl 2,6-dimethyl-4-(3-phenyl-1Hpyrazol-4- yl)-1,4- dihydropyridine-3,5dicarboxylate ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2012, 68 : O922 - +